These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 7565352)

  • 1. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.
    Nath R; Anderson LL; Luxton G; Weaver KA; Williamson JF; Meigooni AS
    Med Phys; 1995 Feb; 22(2):209-34. PubMed ID: 7565352
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for a dose calibration protocol for brachytherapy sources.
    Meli JA
    Med Phys; 2007 Jan; 34(1):367-8; author reply 369-70. PubMed ID: 17278523
    [No Abstract]   [Full Text] [Related]  

  • 3. On the use of apparent activity (Aapp) for treatment planning of 125I and 103Pd interstitial brachytherapy sources: recommendations of the American Association of Physicists in Medicine radiation therapy committee subcommittee on low-energy brachytherapy source dosimetry.
    Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Rivard MJ; Ibbott G
    Med Phys; 1999 Dec; 26(12):2529-30. PubMed ID: 10619235
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
    Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.
    DeWerd LA; Huq MS; Das IJ; Ibbott GS; Hanson WF; Slowey TW; Williamson JF; Coursey BM;
    Med Phys; 2004 Mar; 31(3):675-81. PubMed ID: 15070265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group 43" [Med. Phys. 22, 209-234 (1995)]. American Association of Physicists in Medicine.
    Rivard MJ
    Med Phys; 1999 Nov; 26(11):2514. PubMed ID: 10587242
    [No Abstract]   [Full Text] [Related]  

  • 8. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
    Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF
    Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM; Pinillos-Ashton L; Mettler F;
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on "Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43" [Med. Phys. 22, 209-234 (1995)].
    Jones D; Washington JT; Christopherson DA
    Med Phys; 1995 Aug; 22(8):1349, 1351. PubMed ID: 7476725
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
    Nuttens VE; Lucas S
    Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to "Comment on 'Dosimetry of interstitial brachytherapy sources: recommendation of the AAPM Radiation Therapy Committee Task Group 43' " [Med. Phys. 26, 2514 (1999)]. American Association of Physicists in Medicine.
    Meigooni AS; Nath R
    Med Phys; 2000 Jan; 27(1):265. PubMed ID: 10659766
    [No Abstract]   [Full Text] [Related]  

  • 14. The coupling of anisotropy and radial dose functions for 103Pd and 125I for use with a commercial treatment planning system.
    Prete JJ; Bice WS; Dubois DF; Prestidge BR
    Med Phys; 1997 Apr; 24(4):523-5. PubMed ID: 9127302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
    Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
    Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
    Nath R; Yue N; Roa E
    Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "Update of AAPM Task Group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations" [Med. Phys. 31, 633-674 (2004)].
    Meigooni AS; Rachabatthula V; Awan SB; Koona RA
    Med Phys; 2005 Jun; 32(6):1820-1; author reply 1822-4. PubMed ID: 16013739
    [No Abstract]   [Full Text] [Related]  

  • 18. A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems: regarding Luse et al. IJROBP 37:737-741; 1997.
    Rustgi SN
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):243. PubMed ID: 10477029
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters.
    Butler WM; Stewart RR; Merrick GS
    Brachytherapy; 2011; 10(1):16-28. PubMed ID: 20149981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry.
    Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Ibbott G
    Med Phys; 1999 Apr; 26(4):570-3. PubMed ID: 10227361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.